开源证券04月09日发布研报称,给予健康元(600380.SH,最新价:10.4元)买入评级。评级理由主要包括:1)吸入制剂受左沙影响收入有所波动,保健品业务持续攀升;2)聚焦呼吸疾病全剂型矩阵,创新药布局加速。风险提示:行业政策变化风险、新药研发风险、原材料供应和价格波动风险等。(文章来源:每日经济新闻) 海量资讯、精准解读,尽在新浪财经APP
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.